It has also been reported that curcumin, an active ingredient in Curcuma longa, may be a DYRK2 inhibitor and decreases 26S proteasome activity through DYRK2 inhibition in TNBC and multiple myeloma cell lines, thereby inhibiting tumor proliferation [46]. Here, DYRK2 is linked to AL amyloidosis.